Singapore markets closed

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0420+0.0010 (+2.44%)
At close: 03:14PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 32.27M
Enterprise value 32.19M
Trailing P/E 1.42
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.31
Price/book (mrq)4.21
Enterprise value/revenue 5.31
Enterprise value/EBITDA -4.57

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-49.40%
S&P500 52-week change 322.36%
52-week high 30.1000
52-week low 30.0330
50-day moving average 30.0454
200-day moving average 30.0461

Share statistics

Avg vol (3-month) 3123.63k
Avg vol (10-day) 3108.95k
Shares outstanding 5768.32M
Implied shares outstanding 6768.32M
Float 8382.45M
% held by insiders 150.99%
% held by institutions 11.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -158.41%
Operating margin (ttm)-129.72%

Management effectiveness

Return on assets (ttm)-20.80%
Return on equity (ttm)-76.96%

Income statement

Revenue (ttm)6.06M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)5.70%
Gross profit (ttm)N/A
EBITDA -6.92M
Net income avi to common (ttm)-9.6M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.09M
Total cash per share (mrq)0.01
Total debt (mrq)6.01M
Total debt/equity (mrq)78.52%
Current ratio (mrq)1.38
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-6.56M
Levered free cash flow (ttm)-6.06M